251 related articles for article (PubMed ID: 34597346)
1. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
Meyers JM; Ramanathan M; Shanderson RL; Beck A; Donohue L; Ferguson I; Guo MG; Rao DS; Miao W; Reynolds D; Yang X; Zhao Y; Yang YY; Blish C; Wang Y; Khavari PA
PLoS Pathog; 2021 Oct; 17(10):e1009412. PubMed ID: 34597346
[TBL] [Abstract][Full Text] [Related]
2. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
Meyers JM; Ramanathan M; Shanderson RL; Donohue L; Ferguson I; Guo MG; Rao DS; Miao W; Reynolds D; Yang X; Zhao Y; Yang YY; Wang Y; Khavari PA
bioRxiv; 2021 Feb; ():. PubMed ID: 33655243
[TBL] [Abstract][Full Text] [Related]
3. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
[TBL] [Abstract][Full Text] [Related]
4. Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2.
Prates ET; Garvin MR; Pavicic M; Jones P; Shah M; Demerdash O; Amos BK; Geiger A; Jacobson D
Mol Biol Evol; 2021 Jan; 38(2):702-715. PubMed ID: 32941612
[TBL] [Abstract][Full Text] [Related]
5. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
7. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
Yuan S; Peng L; Park JJ; Hu Y; Devarkar SC; Dong MB; Shen Q; Wu S; Chen S; Lomakin IB; Xiong Y
Mol Cell; 2020 Dec; 80(6):1055-1066.e6. PubMed ID: 33188728
[TBL] [Abstract][Full Text] [Related]
8. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
Kehrer T; Cupic A; Ye C; Yildiz S; Bouhaddou M; Crossland NA; Barrall EA; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena I; Aslam S; Saqi A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Ak B; Marin A; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
Cell Host Microbe; 2023 Oct; 31(10):1668-1684.e12. PubMed ID: 37738983
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Cell Signaling by SARS-CoV-2.
Suryawanshi RK; Koganti R; Agelidis A; Patil CD; Shukla D
Trends Microbiol; 2021 Mar; 29(3):224-237. PubMed ID: 33451855
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
Banerjee AK; Blanco MR; Bruce EA; Honson DD; Chen LM; Chow A; Bhat P; Ollikainen N; Quinodoz SA; Loney C; Thai J; Miller ZD; Lin AE; Schmidt MM; Stewart DG; Goldfarb D; De Lorenzo G; Rihn SJ; Voorhees RM; Botten JW; Majumdar D; Guttman M
Cell; 2020 Nov; 183(5):1325-1339.e21. PubMed ID: 33080218
[TBL] [Abstract][Full Text] [Related]
12. Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism.
Wong HT; Cheung V; Salamango DJ
J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35187564
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
Hall R; Guedán A; Yap MW; Young GR; Harvey R; Stoye JP; Bishop KN
PLoS Pathog; 2022 Aug; 18(8):e1010349. PubMed ID: 36007063
[TBL] [Abstract][Full Text] [Related]
14. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
Selkrig J; Stanifer M; Mateus A; Mitosch K; Barrio-Hernandez I; Rettel M; Kim H; Voogdt CGP; Walch P; Kee C; Kurzawa N; Stein F; Potel C; Jarzab A; Kuster B; Bartenschlager R; Boulant S; Beltrao P; Typas A; Savitski MM
Mol Syst Biol; 2021 Feb; 17(2):e10188. PubMed ID: 33590968
[TBL] [Abstract][Full Text] [Related]
16. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
Koudelka T; Boger J; Henkel A; Schönherr R; Krantz S; Fuchs S; Rodríguez E; Redecke L; Tholey A
Proteomics; 2021 Jan; 21(2):e2000246. PubMed ID: 33111431
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection.
Mhlekude B; Postmus D; Stenzel S; Weiner J; Jansen J; Zapatero-Belinchón FJ; Olmer R; Richter A; Heinze J; Heinemann N; Mühlemann B; Schroeder S; Jones TC; Müller MA; Drosten C; Pich A; Thiel V; Martin U; Niemeyer D; Gerold G; Beule D; Goffinet C
PLoS Pathog; 2023 Sep; 19(9):e1011657. PubMed ID: 37747932
[TBL] [Abstract][Full Text] [Related]
18. Activation and evasion of type I interferon responses by SARS-CoV-2.
Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-encoded inhibitors of human LINE-1 retrotransposition.
Li Y; Yang J; Shen S; Wang W; Liu N; Guo H; Wei W
J Med Virol; 2023 Jan; 95(1):e28135. PubMed ID: 36085352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
